Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
ID: 347718Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program seeks to support innovative projects that enhance the prevention, diagnosis, treatment, and care for individuals affected by AD/ADRD, while also addressing the shortage of scientists in this critical research area. Eligible applicants include a wide range of institutions, such as higher education institutions, community-based organizations, and tribal colleges, with funding of up to $100,000 per year available for projects lasting a maximum of two years. Applications are accepted on a rolling basis until March 17, 2026, and interested parties can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-179.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) has reissued the Small Research Grant Program (R03) targeting emerging researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The program aims to stimulate innovative research to enhance prevention, diagnosis, treatment, and caregiving for individuals with AD/ADRD while addressing the shortage of scientists in this critical area. The program encourages applications from early stage investigators and researchers lacking major prior funding in the field. Funding of up to $100,000 per year is available for projects lasting a maximum of two years, with an anticipated total of 12 awards worth $1.8 million in fiscal year 2024. Application submissions are due every few months, starting from July 19, 2023, until March 17, 2026. Various research topics are encouraged, ranging from understanding the disease trajectory and identifying health disparities to exploring molecular pathways and behavioral interventions. Eligibility extends to numerous institutional types, including higher education institutions and non-profits. Applications must adhere strictly to specified guidelines, and submissions must be made electronically through the NIH's platform. This initiative reflects NIH's strategic goals to build a diverse workforce equipped to tackle AD/ADRD research challenges.
    Similar Opportunities
    Loading similar opportunities...